aluates Reports

$ 0.0

Automative

Global Single Cancer Screening Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-7V18804

Global Single Cancer Screening Market Research Report 2024

BUY CHAPTERS

Global Single Cancer Screening Market Research Report 2026

Code: QYRE-Auto-7V18804

Report

2026-01-23

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GRAIL

Exact Sciences

Oncognostic GmbH

Epigenomics

Abbott

Qiagen NV

iStat Biomedical

Genetron Health

New Horizon Health

Burning Rock

Berry Oncology

Shanghai Kunyuan Biotechnology

Single Cancer Screening Market Size

The global Single Cancer Screening market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 3724 million by 2032, at a CAGR of 13.5% from 2026 to 2032.

Single Cancer Screening Market

Single cancer screening refers to screening procedures focused on a specific type of cancer, aimed at early detection to improve treatment outcomes and survival rates. This type of screening typically includes specific tests for certain cancers, such as mammography for breast cancer, Pap smears for cervical cancer, or blood tests for prostate cancer. The implementation of single cancer screening helps identify high-risk populations and provides timely interventions, effectively reducing cancer-related mortality.

The North American market for Single Cancer Screening is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Single Cancer Screening is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Single Cancer Screening in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Single Cancer Screening include Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Single Cancer Screening market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single Cancer Screening. The Single Cancer Screening market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Single Cancer Screening market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Single Cancer Screening manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Single Cancer Screening Market Report

Report Metric	Details
Report Name	Single Cancer Screening Market
Accounted market size in 2025	US$ 1553 million
Forecasted market size in 2032	US$ 3724 million
CAGR	13.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Colorectal Cancer Liver Cancer Lung Cancer Other
Segment by Application	Hospital Physical Examination Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Single Cancer Screening companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Single Cancer Screening Market growing?

Ans: The Single Cancer Screening Market witnessing a CAGR of 13.5% during the forecast period 2026-2032.

What is the Single Cancer Screening Market size in 2032?

Ans: The Single Cancer Screening Market size in 2032 will be US$ 3724 million.

Who are the main players in the Single Cancer Screening Market report?

Ans: The main players in the Single Cancer Screening Market are Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology

What are the Application segmentation covered in the Single Cancer Screening Market report?

Ans: The Applications covered in the Single Cancer Screening Market report are Hospital, Physical Examination Center, Other

What are the Type segmentation covered in the Single Cancer Screening Market report?

Ans: The Types covered in the Single Cancer Screening Market report are Colorectal Cancer, Liver Cancer, Lung Cancer, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Single Cancer Screening Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Colorectal Cancer

1.2.3 Liver Cancer

1.2.4 Lung Cancer

1.2.5 Other

1.3 Market by Application

1.3.1 Global Single Cancer Screening Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Physical Examination Center

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Single Cancer Screening Market Perspective (2021–2032)

2.2 Global Single Cancer Screening Growth Trends by Region

2.2.1 Global Single Cancer Screening Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Single Cancer Screening Historic Market Size by Region (2021–2026)

2.2.3 Single Cancer Screening Forecasted Market Size by Region (2027–2032)

2.3 Single Cancer Screening Market Dynamics

2.3.1 Single Cancer Screening Industry Trends

2.3.2 Single Cancer Screening Market Drivers

2.3.3 Single Cancer Screening Market Challenges

2.3.4 Single Cancer Screening Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Single Cancer Screening Players by Revenue

3.1.1 Global Top Single Cancer Screening Players by Revenue (2021–2026)

3.1.2 Global Single Cancer Screening Revenue Market Share by Players (2021–2026)

3.2 Global Top Single Cancer Screening Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Single Cancer Screening Revenue

3.4 Global Single Cancer Screening Market Concentration Ratio

3.4.1 Global Single Cancer Screening Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Single Cancer Screening Revenue in 2025

3.5 Global Key Players of Single Cancer Screening Head Offices and Areas Served

3.6 Global Key Players of Single Cancer Screening, Products and Applications

3.7 Global Key Players of Single Cancer Screening, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Single Cancer Screening Breakdown Data by Type

4.1 Global Single Cancer Screening Historic Market Size by Type (2021–2026)

4.2 Global Single Cancer Screening Forecasted Market Size by Type (2027–2032)

5 Single Cancer Screening Breakdown Data by Application

5.1 Global Single Cancer Screening Historic Market Size by Application (2021–2026)

5.2 Global Single Cancer Screening Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Single Cancer Screening Market Size (2021–2032)

6.2 North America Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Single Cancer Screening Market Size by Country (2021–2026)

6.4 North America Single Cancer Screening Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Single Cancer Screening Market Size (2021–2032)

7.2 Europe Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Single Cancer Screening Market Size by Country (2021–2026)

7.4 Europe Single Cancer Screening Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Single Cancer Screening Market Size (2021–2032)

8.2 Asia-Pacific Single Cancer Screening Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Single Cancer Screening Market Size by Region (2021–2026)

8.4 Asia-Pacific Single Cancer Screening Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Single Cancer Screening Market Size (2021–2032)

9.2 Latin America Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Single Cancer Screening Market Size by Country (2021–2026)

9.4 Latin America Single Cancer Screening Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Single Cancer Screening Market Size (2021–2032)

10.2 Middle East & Africa Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Single Cancer Screening Market Size by Country (2021–2026)

10.4 Middle East & Africa Single Cancer Screening Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Grail

11.1.1 Grail Company Details

11.1.2 Grail Business Overview

11.1.3 Grail Single Cancer Screening Introduction

11.1.4 Grail Revenue in Single Cancer Screening Business (2021–2026)

11.1.5 Grail Recent Development

11.2 Exact Sciences

11.2.1 Exact Sciences Company Details

11.2.2 Exact Sciences Business Overview

11.2.3 Exact Sciences Single Cancer Screening Introduction

11.2.4 Exact Sciences Revenue in Single Cancer Screening Business (2021–2026)

11.2.5 Exact Sciences Recent Development

11.3 Oncognostic

11.3.1 Oncognostic Company Details

11.3.2 Oncognostic Business Overview

11.3.3 Oncognostic Single Cancer Screening Introduction

11.3.4 Oncognostic Revenue in Single Cancer Screening Business (2021–2026)

11.3.5 Oncognostic Recent Development

11.4 Epigenomics

11.4.1 Epigenomics Company Details

11.4.2 Epigenomics Business Overview

11.4.3 Epigenomics Single Cancer Screening Introduction

11.4.4 Epigenomics Revenue in Single Cancer Screening Business (2021–2026)

11.4.5 Epigenomics Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Single Cancer Screening Introduction

11.5.4 Abbott Revenue in Single Cancer Screening Business (2021–2026)

11.5.5 Abbott Recent Development

11.6 Qiagen

11.6.1 Qiagen Company Details

11.6.2 Qiagen Business Overview

11.6.3 Qiagen Single Cancer Screening Introduction

11.6.4 Qiagen Revenue in Single Cancer Screening Business (2021–2026)

11.6.5 Qiagen Recent Development

11.7 iStat Biomedical

11.7.1 iStat Biomedical Company Details

11.7.2 iStat Biomedical Business Overview

11.7.3 iStat Biomedical Single Cancer Screening Introduction

11.7.4 iStat Biomedical Revenue in Single Cancer Screening Business (2021–2026)

11.7.5 iStat Biomedical Recent Development

11.8 Genetron Health

11.8.1 Genetron Health Company Details

11.8.2 Genetron Health Business Overview

11.8.3 Genetron Health Single Cancer Screening Introduction

11.8.4 Genetron Health Revenue in Single Cancer Screening Business (2021–2026)

11.8.5 Genetron Health Recent Development

11.9 New Horizon Health

11.9.1 New Horizon Health Company Details

11.9.2 New Horizon Health Business Overview

11.9.3 New Horizon Health Single Cancer Screening Introduction

11.9.4 New Horizon Health Revenue in Single Cancer Screening Business (2021–2026)

11.9.5 New Horizon Health Recent Development

11.10 Burning Rock

11.10.1 Burning Rock Company Details

11.10.2 Burning Rock Business Overview

11.10.3 Burning Rock Single Cancer Screening Introduction

11.10.4 Burning Rock Revenue in Single Cancer Screening Business (2021–2026)

11.10.5 Burning Rock Recent Development

11.11 Berry Oncology

11.11.1 Berry Oncology Company Details

11.11.2 Berry Oncology Business Overview

11.11.3 Berry Oncology Single Cancer Screening Introduction

11.11.4 Berry Oncology Revenue in Single Cancer Screening Business (2021–2026)

11.11.5 Berry Oncology Recent Development

11.12 Shanghai Kunyuan Biotechnology

11.12.1 Shanghai Kunyuan Biotechnology Company Details

11.12.2 Shanghai Kunyuan Biotechnology Business Overview

11.12.3 Shanghai Kunyuan Biotechnology Single Cancer Screening Introduction

11.12.4 Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (2021–2026)

11.12.5 Shanghai Kunyuan Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GRAIL

Exact Sciences

Oncognostic GmbH

Epigenomics

Abbott

Qiagen NV

iStat Biomedical

Genetron Health

New Horizon Health

Burning Rock

Berry Oncology

Shanghai Kunyuan Biotechnology

List of Tables

Table 1. Global Single Cancer Screening Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Colorectal Cancer

Table 3. Key Players of Liver Cancer

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other

Table 6. Global Single Cancer Screening Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Single Cancer Screening Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Single Cancer Screening Market Size by Region (US$ Million), 2021–2026

Table 9. Global Single Cancer Screening Market Share by Region (2021–2026)

Table 10. Global Single Cancer Screening Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Single Cancer Screening Market Share by Region (2027–2032)

Table 12. Single Cancer Screening Market Trends

Table 13. Single Cancer Screening Market Drivers

Table 14. Single Cancer Screening Market Challenges

Table 15. Single Cancer Screening Market Restraints

Table 16. Global Single Cancer Screening Revenue by Players (US$ Million), 2021–2026

Table 17. Global Single Cancer Screening Market Share by Players (2021–2026)

Table 18. Global Top Single Cancer Screening Players by Tier (Tier 1, Tier 2, and Tier 3), based on Single Cancer Screening Revenue, 2025

Table 19. Ranking of Global Top Single Cancer Screening Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Single Cancer Screening Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Single Cancer Screening, Headquarters and Area Served

Table 22. Global Key Players of Single Cancer Screening, Products and Applications

Table 23. Global Key Players of Single Cancer Screening, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Single Cancer Screening Market Size by Type (US$ Million), 2021–2026

Table 26. Global Single Cancer Screening Revenue Market Share by Type (2021–2026)

Table 27. Global Single Cancer Screening Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Single Cancer Screening Revenue Market Share by Type (2027–2032)

Table 29. Global Single Cancer Screening Market Size by Application (US$ Million), 2021–2026

Table 30. Global Single Cancer Screening Revenue Market Share by Application (2021–2026)

Table 31. Global Single Cancer Screening Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Single Cancer Screening Revenue Market Share by Application (2027–2032)

Table 33. North America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Single Cancer Screening Market Size by Country (US$ Million), 2021–2026

Table 35. North America Single Cancer Screening Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Single Cancer Screening Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Single Cancer Screening Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Single Cancer Screening Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Single Cancer Screening Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Single Cancer Screening Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Single Cancer Screening Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Single Cancer Screening Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Single Cancer Screening Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Single Cancer Screening Market Size by Country (US$ Million), 2027–2032

Table 48. Grail Company Details

Table 49. Grail Business Overview

Table 50. Grail Single Cancer Screening Product

Table 51. Grail Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 52. Grail Recent Development

Table 53. Exact Sciences Company Details

Table 54. Exact Sciences Business Overview

Table 55. Exact Sciences Single Cancer Screening Product

Table 56. Exact Sciences Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 57. Exact Sciences Recent Development

Table 58. Oncognostic Company Details

Table 59. Oncognostic Business Overview

Table 60. Oncognostic Single Cancer Screening Product

Table 61. Oncognostic Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 62. Oncognostic Recent Development

Table 63. Epigenomics Company Details

Table 64. Epigenomics Business Overview

Table 65. Epigenomics Single Cancer Screening Product

Table 66. Epigenomics Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 67. Epigenomics Recent Development

Table 68. Abbott Company Details

Table 69. Abbott Business Overview

Table 70. Abbott Single Cancer Screening Product

Table 71. Abbott Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 72. Abbott Recent Development

Table 73. Qiagen Company Details

Table 74. Qiagen Business Overview

Table 75. Qiagen Single Cancer Screening Product

Table 76. Qiagen Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 77. Qiagen Recent Development

Table 78. iStat Biomedical Company Details

Table 79. iStat Biomedical Business Overview

Table 80. iStat Biomedical Single Cancer Screening Product

Table 81. iStat Biomedical Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 82. iStat Biomedical Recent Development

Table 83. Genetron Health Company Details

Table 84. Genetron Health Business Overview

Table 85. Genetron Health Single Cancer Screening Product

Table 86. Genetron Health Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 87. Genetron Health Recent Development

Table 88. New Horizon Health Company Details

Table 89. New Horizon Health Business Overview

Table 90. New Horizon Health Single Cancer Screening Product

Table 91. New Horizon Health Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 92. New Horizon Health Recent Development

Table 93. Burning Rock Company Details

Table 94. Burning Rock Business Overview

Table 95. Burning Rock Single Cancer Screening Product

Table 96. Burning Rock Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 97. Burning Rock Recent Development

Table 98. Berry Oncology Company Details

Table 99. Berry Oncology Business Overview

Table 100. Berry Oncology Single Cancer Screening Product

Table 101. Berry Oncology Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 102. Berry Oncology Recent Development

Table 103. Shanghai Kunyuan Biotechnology Company Details

Table 104. Shanghai Kunyuan Biotechnology Business Overview

Table 105. Shanghai Kunyuan Biotechnology Single Cancer Screening Product

Table 106. Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (US$ Million), 2021–2026

Table 107. Shanghai Kunyuan Biotechnology Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Single Cancer Screening Picture

Figure 2. Global Single Cancer Screening Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Single Cancer Screening Market Share by Type: 2025 vs 2032

Figure 4. Colorectal Cancer Features

Figure 5. Liver Cancer Features

Figure 6. Lung Cancer Features

Figure 7. Other Features

Figure 8. Global Single Cancer Screening Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Single Cancer Screening Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Physical Examination Center Case Studies

Figure 12. Other Case Studies

Figure 13. Single Cancer Screening Report Years Considered

Figure 14. Global Single Cancer Screening Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Single Cancer Screening Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Single Cancer Screening Market Share by Region: 2025 vs 2032

Figure 17. Global Single Cancer Screening Market Share by Players in 2025

Figure 18. Global Single Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Single Cancer Screening Revenue in 2025

Figure 20. North America Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Single Cancer Screening Market Share by Country (2021–2032)

Figure 22. United States Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Single Cancer Screening Market Share by Country (2021–2032)

Figure 26. Germany Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Single Cancer Screening Market Share by Region (2021–2032)

Figure 34. China Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Single Cancer Screening Market Share by Country (2021–2032)

Figure 42. Mexico Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Single Cancer Screening Market Share by Country (2021–2032)

Figure 46. Israel Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Grail Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 50. Exact Sciences Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 51. Oncognostic Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 52. Epigenomics Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 53. Abbott Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 54. Qiagen Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 55. iStat Biomedical Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 56. Genetron Health Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 57. New Horizon Health Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 58. Burning Rock Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 59. Berry Oncology Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 60. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Single Cancer Screening Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mobile Cancer Screening Devices Market Insights Forecast to 2030

Global Cervical Screening System Market Research Report 2024

Global Cervical Cancer Screening Market Research Report 2024

Global Colorectal Cancer Screening Test Market Research Report 2024

Global Breast Cancer Testing Market Insights Forecast to 2030

Global Cancer Screening Vehicles Market Research Report 2024

Global Portable Cancer Screen Device Market Research Report 2024

Global Early Detection of Multiple Cancers Market Research Report 2024

Global Colposcopy Market Insights Forecast to 2030

Global Multi Cancer Detection Blood Test Market Research Report 2024

Global Canine Cancer Screening Market Research Report 2024

Global Cancer Biopsy Market Size Status and Forecast 2021 2027

Precision Cancer Imaging Market

Global Precision Cancer Tests Market Research Report 2024

Global Pan cancer Genetic Testing Market Research Report 2025

Multicancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Early Detection and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Single Dose Radiotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Diagnostic And Screening Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions